Folate-related nutrients, genetic polymorphisms, and colorectal cancer risk: The Fukuoka colorectal cancer study

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 11, 2013, Pages 6249-6256

  Morita, Makiko ^a   Yin, Guang ^a   Yoshimitsu, Shin ichiro ^a   Ohnaka, Keizo ^a   Toyomura, Kengo ^a   Kono, Suminori ^a   Ueki, Takashi ^a   Tanaka, Masao ^a   Kakeji, Yoshihiro ^a   Maehara, Yoshihiko ^a   Okamura, Takeshi ^b   Ikejiri, Koji ^c   Futami, Kitaroh ^d   Maekawa, Takafumi ^d   Yasunami, Yohichi ^d   Takenaka, Kenji ^d   Ichimiya, Hitoshi ^d   Terasaka, Reiji ^e  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL KYUSHU CANCER CENTER   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^d FUKUOKA UNIVERSITY   (Japan)

^e FUKUOKA RED CROSS HOSPITAL   (Japan)

Author keywords

B vitamins; Case control study; Colorectal cancer; Methionine synthase; Thymidylate synthase

Indexed keywords

5 METHYLTETRAHYDROFOLATE HOMOCYSTEINE METHYLTRANSFERASE; FOLIC ACID; METHIONINE; MTR PROTEIN, HUMAN; THYMIDYLATE SYNTHASE; VITAMIN;

ADULT; AGED; ALLELE; CASE CONTROL STUDY; COLORECTAL NEOPLASMS; EPIDEMIOLOGY; FEMALE; FOOD; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; JAPAN; MALE; META ANALYSIS; METABOLISM; MIDDLE AGED; RISK; YOUNG ADULT;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; FOLIC ACID; FOOD; GENOTYPE; HUMANS; JAPAN; MALE; METHIONINE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK; THYMIDYLATE SYNTHASE; VITAMINS; YOUNG ADULT;

EID: 84892448952     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.11.6249     Document Type: Article

References (52)

1. Chen J, Giovannucci E, Kelsey K, et al (1996). A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res, 56, 4862-4.
2. Chen J, Hunter DJ, Stampfer MJ, et al (2003). Polymorphism in the thymidylate synthase promoter enhancer region modifies the risk and survival of colorectal cancer. Cancer Epidemiol Biomarkers Prev, 12, 958-62.
3. De Vogel S, Wouters KA, Gottschalk RW, et al (2009). Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer. Cancer Epidemiol Biomarkers Prev, 18, 3086-96.
4. Ding W, Zhou DL, Jiang X, Lu LS (2013). Methionine synthase A2756G polymorphism and risk of colorectal adenoma and cancer: evidence based on 27 studies. PLoS One, 9, 60508.
5. Eussen SJ, Vollset SE, Igland J, et al (2010). Plasma folate, related genetic variants, and colorectal cancer risk in EPIC. Cancer Epidemiol Biomarkers Prev, 19, 1328-40.
6. Eussen SJ, Vollset SE, Hustad S, et al (2010). Plasma vitamins B2, B6, and B12, and related genetic variants as predictors of colorectal cancer risk. Cancer Epidemiol Biomarkers Prev, 19, 2549-61.
7. Giovannucci E, Rimm EB, Ascherio A, et al (1995). Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst, 87, 265-73.
8. Harnack L, Jacobs DR Jr, Nicodemus K, et al (2002). Relationship of folate, vitamin B6, vitamin B12, and methionine intake to incidence of colorectal cancers. Nutr Cancer, 43, 152-8.
9. Huang Y, Han S, Li Y, Mao Y, Xie Y (2007). Different roles of MTHFR C677T and A1298C polymorphisms in colorectal adenoma and colorectal cancer: a meta-analysis. J Hum Genet, 52, 73-85.
10. Hubner RA, Houlston RS (2007). MTHFR C677T and colorectal cancer risk: A meta-analysis of 25 populations. Int J Cancer, 120, 1027-35.
11. Hubner RA, Houlston RS (2009). Folate and colorectal cancer prevention. Br J Cancer, 100, 233-9.
12. Ishihara J, Otani T, Inoue M, et al (2007). Low intake of vitamin B-6 is associated with increased risk of colorectal cancer in Japanese men. J Nutr, 137, 1808-14.
13. Isomura K, Kono S, Moore MA, et al (2006). Physical activity and colorectal cancer: the Fukuoka colorectal cancer study. Cancer Sci, 97, 1099-104.
14. Kennedy DA, Stern SJ, Moretti M, et al (2011). Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis. Cancer Epidemiol, 35, 2-10.
15. Kim DH, Smith-Warner SA, Spiegelman D, et al (2010). Pooled analyses of 13 prospective cohort studies on folate intake and colon cancer. Cancer Causes Control, 21, 1919-30.
16. Kim J, Cho YA, Kim DH, et al (2012). Dietary intake of folate and alcohol, MTHFR C677T polymorphism, and colorectal cancer risk in Korea. Am J Clin Nutr, 95, 405-12.
17. Kim YI (2008). Folic acid supplementation and cancer risk: point. Cancer Epidemiol Biomarkers Prev, 17, 2220-5.
18. Kimura Y, Kono S, Toyomura K, et al (2007). Meat, fish and fat intake in relation to subsite-specific risk of colorectal cancer: the Fukuoka colorectal cancer study. Cancer Sci, 98, 590-7.
19. Kono S, Toyomura K, Yin G, Nagano J, Mizoue T (2004). A case-control study of colorectal cancer in relation to lifestyle factors and genetic polymorphisms: design and conduct of the Fukuoka colorectal cancer study. Asian Pac J Cancer Prev, 5, 393-400.
20. Kono S, Chen K (2005). Genetic polymorphisms of methylenetetrahydrofolate reductase and colorectal cancer and adenoma. Cancer Sci, 96, 535-42.
21. Larsson SC, Orsini N, Wolk A (2010). Vitamin B6 and risk of colorectal cancer: a meta-analysis of prospective studies. JAMA, 303, 1077-83.
22. Le Marchand L, Donlon T, Hankin JH, et al (2002). B-vitamin intake, metabolic genes, and colorectal cancer risk (United States). Cancer Causes Control, 13, 239-48.
23. Le Marchand L, Wilkens LR, Kolonel LN, Henderson BE (2005). The MTHFR C677T polymorphism and colorectal cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev, 14, 1198-203.
24. Le Marchand L, White KK, Nomura AM, et al (2009). Plasma levels of B vitamins and colorectal cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev, 18, 2195-201.
25. Ma J, Stampfer MJ, Giovannucci E, et al (1997). Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res, 57, 1098-102.
26. Ma J, Stampfer MJ, Christensen B, et al (1999). A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev, 8, 825-9.
27. Mason JB, Choi SW (2005). Effects of alcohol on folate metabolism: implications for carcinogenesis. Alcohol, 35, 235-41.
28. Matsuo K, Ito H, Wakai K, et al (2005). One-carbon metabolism related gene polymorphisms interact with alcohol drinking to influence the risk of colorectal cancer in Japan. Carcinogenesis, 26, 2164-71.
29. Mizoue T, Kimura Y, Toyomura K, et al (2008). Calcium, dairy foods, vitamin D, and colorectal cancer risk: the Fukuoka Colorectal Cancer Study. Cancer Epidemiol Biomarkers Prev, 17, 2800-7.
30. Murtaugh MA, Curtin K, Sweeney C, et al (2007). Dietary intake of folate and co-factors in folate metabolism, MTHFR polymorphisms, and reduced rectal cancer. Cancer Causes Control, 18, 153-63.
31. Razzak AA, Oxentenko AS, Vierkant RA, et al (2012). Associations between intake of folate and related micronutrients with molecularly defined colorectal cancer risks in the Iowa women's health study. Nutr Cancer, 64, 899-910.
32. Sanjoaquin MA, Allen N, Couto E, Roddam AW, Key TJ (2005). Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer, 113, 825-8.
33. Sharp L, Little J (2004). Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol, 159, 423-43.
34. Sharp L, Little J, Brockton NT, et al (2008). Polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene, intakes of folate and related B vitamins and colorectal cancer: a case-control study in a population with relatively low folate intake. Br J Nutr, 99, 379-89.
35. Shrubsole MJ, Yang G, Gao YT, et al (2009). Dietary B vitamin and methionine intakes and plasma folate are not associated with colorectal cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev, 18, 1003-6.
36. Stevens VL, McCullough ML, Sun J, et al (2011). High levels of folate from supplements and fortification are not associated with increased risk of colorectal cancer. Gastroenterology, 141, 98-105
37. Theodoratou E, Farrington SM, Tenesa A, et al (2008). Dietary vitamin B6 intake and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev, 17, 171-82.
38. Trinh BN, Ong CN, Coetzee GA, Yu MC, Laird PW (2002). Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels. Hum Genet, 111, 299-302.
39. Uchida K, Kimura Y, Shirota T, Kono S (2007). Validity and reproducibility of the PC-assisted dietary interview used in the Fukuoka colorectal cancer study. Asian Pac J Cancer Prev, 8, 583-90.
40. Ulrich CM, Bigler J, Bostick R, Fosdick L, Potter JD (2002). Thymidylate synthase promoter polymorphism, interaction with folate intake, and risk of colorectal adenomas. Cancer Res, 62, 3361-4.
41. Ulrich CM (2005). Nutrigenetics in cancer research: folate metabolism and colorectal cancer. J Nutr, 135, 2698-702.
42. Ulrich CM, Curtin K, Potter JD, et al (2005). Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer. Cancer Epidemiol Biomarkers Prev, 14, 2509-16.
43. Ulvik A, Vollset SE, Hansen S, et al (2004). Colorectal cancer and the methylenetetrahydrofolate reductase 677C→T and methionine synthase 2756A→G polymorphisms: a study of 2,168 case-control pairs from the JANUS cohort. Cancer Epidemiol Biomarkers Prev, 13, 2175-80.
44. Van Guelpen B, Hultdin J, Johansson I, et al (2006). Low folate levels may protect against colorectal cancer. Gut, 55, 1461-6.
45. Weinstein SJ, Albanes D, Selhub J, et al (2008). One-carbon metabolism biomarkers and risk of colon and rectal cancers. Cancer Epidemiol Biomarkers Prev, 17, 3233-40.
46. Willett W, Stampfer MJ (1986). Total energy intake: implications for epidemiologic analyses. Am J Epidemiol, 124, 17-27.
47. Williams EA (2012). Folate, colorectal cancer and the involvement of DNA methylation. Proc Nutr Soc, 71, 592-7.
48. Winder T, Lenz HJ (2010). Molecular predictive and prognostic markers in colon cancer. Cancer Treat Rev, 36, 550-6.
49. Yang Z, Zhang XF, Liu HX, Hao YS, Zhao CL (2012). MTHFR C677T polymorphism and colorectal cancer risk in Asians, a meta-analysis of 21 studies. Asian Pac J Cancer Prev, 13, 1203-8.
50. Yin G, Kono S, Toyomura K, et al (2004). Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and colorectal cancer: the Fukuoka colorectal cancer study. Cancer Sci, 95, 908-13.
51. Zhang X, Lee JE, Ma J, et al (2012). Prospective cohort studies of vitamin B6 intake and colorectal cancer incidence: modification by time. Am J Clin Nutr, 96, 874-81.
52. Zschäbitz S, Cheng TY, Neuhouser ML, et al (2013). B vitamin intakes and incidence of colorectal cancer: results from the women's health initiative observational study cohort. Am J Clin Nutr, 97, 332-43.